{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:51:34Z","timestamp":1790142694538,"version":"4.0.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132320-B-320\\u2013002 -MY3"],"award-info":[{"award-number":["NSTC 112\\u20132320-B-320\\u2013002 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132320-B-303\\u2013003"],"award-info":[{"award-number":["NSTC 112\\u20132320-B-303\\u2013003"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113\\u20132320-B-303\\u2013002"],"award-info":[{"award-number":["NSTC 113\\u20132320-B-303\\u2013002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118654","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:05:19Z","timestamp":1760911519000},"page":"118654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Jaceosidin, a natural polymethoxyflavone, suppresses leukemia cell growth and impairs lipid metabolism-dependent survival in AML and cytarabine-resistant cells"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6695-6864","authenticated-orcid":false,"given":"Trung Q.","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6181-7263","authenticated-orcid":false,"given":"Je-Wen","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-1093","authenticated-orcid":false,"given":"Liang-In","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Han","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-828X","authenticated-orcid":false,"given":"Ming-Jiuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4270-7031","authenticated-orcid":false,"given":"Pei-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-350X","authenticated-orcid":false,"given":"Jui-Hung","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2025.118654_bib2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jamaoncol.2017.2714","article-title":"Development and validation of a novel acute myeloid Leukemia-Composite model to estimate risks of mortality","volume":"3","author":"Sorror","year":"2017","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118654_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000536152","article-title":"Pathophysiology of acute myeloid leukemia","volume":"147","author":"Wachter","year":"2024","journal-title":"Acta Haematol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118654_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.17746","article-title":"Updates on targeted therapies for acute myeloid leukaemia","volume":"196","author":"Kayser","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118654_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042362","article-title":"Emerging targeted therapy for specific genomic abnormalities in acute myeloid leukemia","volume":"23","author":"Chi","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118654_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100996","article-title":"Mechanisms of myeloid leukemogenesis: current perspectives and therapeutic objectives","volume":"57","author":"Bouligny","year":"2023","journal-title":"Blood Rev."},{"issue":"11","key":"10.1016\/j.biopha.2025.118654_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/bloodadvances.2018019125","article-title":"Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States","volume":"2","author":"Bhatt","year":"2018","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.biopha.2025.118654_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-019-1626-x","article-title":"Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine","volume":"10","author":"Levin","year":"2019","journal-title":"Cell Death Dis."},{"issue":"16","key":"10.1016\/j.biopha.2025.118654_bib9","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1080\/14656566.2017.1391216","article-title":"Cytarabine and daunorubicin for the treatment of acute myeloid leukemia","volume":"18","author":"Murphy","year":"2017","journal-title":"Expert Opin. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood.V64.1.54.54","article-title":"Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cells","volume":"64","author":"Kufe","year":"1984","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.biopha.2025.118654_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.exphem.2006.01.015","article-title":"Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia","volume":"34","author":"Yin","year":"2006","journal-title":"Exp. Hematol."},{"issue":"22","key":"10.1016\/j.biopha.2025.118654_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228505","article-title":"Deciphering the therapeutic resistance in acute myeloid leukemia","volume":"21","author":"Gurnari","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118654_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.leu.2402114","article-title":"Nucleoside analogues: mechanisms of drug resistance and reversal strategies","volume":"15","author":"Galmarini","year":"2001","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.biopha.2025.118654_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/1042819032000159861","article-title":"Problems related to resistance to cytarabine in acute myeloid leukemia","volume":"45","author":"Cros","year":"2004","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.biopha.2025.118654_bib15","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1248\/bpb.30.2069","article-title":"Resistance to Ara-C up-regulates the activation of NF-kappaB, telomerase activity and fas expression in NALM-6 cells","volume":"30","author":"Kanno","year":"2007","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood.V94.3.1046.415k03_1046_1056","article-title":"Simultaneous activity of MRP1 and pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia","volume":"94","author":"Legrand","year":"1999","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.biopha.2025.118654_bib17","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41375-023-01963-4","article-title":"Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia","volume":"37","author":"Morales","year":"2023","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.biopha.2025.118654_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17081355","article-title":"Understanding and targeting metabolic vulnerabilities in acute myeloid leukemia: an updated comprehensive review","volume":"17","author":"Addanki","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.biopha.2025.118654_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.2022018092","article-title":"Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets","volume":"141","author":"Mishra","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","article-title":"Emerging roles of lipid metabolism in cancer metastasis","volume":"16","author":"Luo","year":"2017","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118654_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2020.10.001","article-title":"Extinguishing the embers: targeting AML metabolism","volume":"27","author":"Culp-Hill","year":"2021","journal-title":"Trends Mol. Med"},{"issue":"6","key":"10.1016\/j.biopha.2025.118654_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065988","article-title":"Variation in lipid species profiles among leukemic cells significantly impacts their sensitivity to the drug targeting of lipid metabolism and the prognosis of AML patients","volume":"24","author":"Lo Presti","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118654_bib23","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/blood-2004-01-0395","article-title":"Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells","volume":"104","author":"Banker","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118654_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MOH.0000000000000853","article-title":"Unraveling lipid metabolism for acute myeloid leukemia therapy","volume":"32","author":"O'Brien","year":"2025","journal-title":"Curr. Opin. Hematol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118654_bib26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2174\/1871520620666200423071759","article-title":"Flavonoid-Based cancer therapy: an updated review","volume":"20","author":"Hosseinzadeh","year":"2020","journal-title":"Anticancer Agents Med Chem."},{"issue":"10","key":"10.1016\/j.biopha.2025.118654_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28104080","article-title":"Application of polyphenols and flavonoids in oncological therapy","volume":"28","author":"Roszkowski","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118654_bib28","doi-asserted-by":"crossref","first-page":"1186023","DOI":"10.3389\/fpls.2023.1186023","article-title":"Integrative analysis of metabolite and transcriptome reveals biosynthetic pathway and candidate genes for eupatilin and jaceosidin biosynthesis in artemisia argyi","volume":"14","author":"Lee","year":"2023","journal-title":"Front Plant Sci."},{"key":"10.1016\/j.biopha.2025.118654_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155502","article-title":"Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3\/HMGB1\/TLR4 signaling pathway","volume":"128","author":"Yao","year":"2024","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.biopha.2025.118654_bib30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1089\/jmf.2020.4739","article-title":"Jaceosidin ameliorates insulin resistance and kidney dysfunction by enhancing insulin receptor signaling and the antioxidant defense system in type 2 diabetic mice","volume":"23","author":"Park","year":"2020","journal-title":"J. Med Food"},{"key":"10.1016\/j.biopha.2025.118654_bib31","doi-asserted-by":"crossref","first-page":"9984330","DOI":"10.1155\/2021\/9984330","article-title":"Protection against Doxorubicin-Related cardiotoxicity by jaceosidin involves the Sirt1 signaling pathway","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ptr.4737","article-title":"Natural flavone jaceosidin is a neuroinflammation inhibitor","volume":"27","author":"Nam","year":"2013","journal-title":"Phytother. Res"},{"key":"10.1016\/j.biopha.2025.118654_bib33","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.biopha.2017.03.023","article-title":"A natural compound jaceosidin ameliorates endoplasmic reticulum stress and insulin resistance via upregulation of SERCA2b","volume":"89","author":"Ouyang","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118654_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118415","article-title":"Artemisia argyi ethanol extract ameliorates nonalcoholic steatohepatitis-induced liver fibrosis by modulating gut microbiota and hepatic signaling","volume":"333","author":"Erdenebileg","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118654_bib35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1381612826666200429095101","article-title":"Jaceosidin: a natural flavone with versatile pharmacological and biological activities","volume":"27","author":"Nageen","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2025.118654_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fct.2012.12.026","article-title":"Jaceosidin, isolated from dietary mugwort (Artemisia princeps), induces G2\/M cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1\/2 activation","volume":"55","author":"Lee","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2025.118654_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/703034","article-title":"Jaceosidin induces apoptosis in U87 glioblastoma cells through G2\/M phase arrest","volume":"2012","author":"Khan","year":"2012","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"24","key":"10.1016\/j.biopha.2025.118654_bib38","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1080\/14786419.2020.1817917","article-title":"Apoptotic effect of jaceosidin on MCF-7 human breast cancer cells through modulation of ERK and p38 MAPK pathways","volume":"35","author":"Ojulari","year":"2021","journal-title":"Nat. Prod. Res"},{"key":"10.1016\/j.biopha.2025.118654_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cbi.2016.10.011","article-title":"Jaceosidin induces apoptosis through bax activation and down-regulation of Mcl-1 and c-FLIP expression in human renal carcinoma caki cells","volume":"260","author":"Woo","year":"2016","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2025.118654_bib40","article-title":"Jaceosidin induces apoptosis in human ovary cancer cells through mitochondrial pathway","author":"Lv","year":"2008","journal-title":"J. Biomed. Biotechnol. 2008"},{"issue":"10","key":"10.1016\/j.biopha.2025.118654_bib41","first-page":"4919","article-title":"Anti-tumor effects of jaceosidin on apoptosis, autophagy, and necroptosis in human glioblastoma multiforme","volume":"11","author":"Park","year":"2021","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118654_bib42","doi-asserted-by":"crossref","first-page":"5765047","DOI":"10.1155\/2018\/5765047","article-title":"The flavonoid jaceosidin from artemisia princeps induces apoptotic cell death and inhibits the akt pathway in oral cancer cells","author":"Han","year":"2018","journal-title":"Evid. Based Complement Altern. Med 2018"},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/13510002.2024.2313366","article-title":"Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways","volume":"29","author":"Liu","year":"2024","journal-title":"Redox Rep."},{"key":"10.1016\/j.biopha.2025.118654_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117327","article-title":"Jaceosidin overcomes osimertinib resistance in lung cancer by inducing G2\/M cycle arrest through targeting DDB1","volume":"499","author":"Chen","year":"2025","journal-title":"Toxicol. Appl. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118654_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051230","article-title":"Cytarabine-Resistant FLT3-ITD leukemia cells are associated with TP53 mutation and multiple pathway Alterations-Possible therapeutic efficacy of cabozantinib","volume":"20","author":"Ko","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118654_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040877","article-title":"Nobiletin promotes megakaryocytic differentiation through the MAPK\/ERK-Dependent EGR1 expression and exerts Anti-Leukemic effects in human chronic myeloid leukemia (CML) K562 cells","volume":"9","author":"Yen","year":"2020","journal-title":"Cells"},{"issue":"98","key":"10.1016\/j.biopha.2025.118654_bib47","doi-asserted-by":"crossref","DOI":"10.3791\/52788","article-title":"Non-invasive imaging of the innate immune response in a zebrafish larval model of streptococcus iniae infection","author":"Harvie","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2025.118654_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110729","article-title":"Pinostrobin modulates FOXO3 expression, nuclear localization, and exerts antileukemic effects in AML cells and zebrafish xenografts","volume":"385","author":"Chen","year":"2023","journal-title":"Chem. Biol. Inter."},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib49","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1038\/s41598-021-85141-5","article-title":"Targeted therapy of human leukemia xenografts in immunodeficient zebrafish","volume":"11","author":"Somasagara","year":"2021","journal-title":"Sci. Rep."},{"issue":"43","key":"10.1016\/j.biopha.2025.118654_bib50","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet"},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101512","article-title":"RNA interference protocol to silence oncogenic drivers in leukemia cell lines","volume":"3","author":"Beyer","year":"2022","journal-title":"STAR Protoc."},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030531","article-title":"Diosmetin exerts synergistic effects in combination with 5-Fluorouracil in colorectal cancer cells","volume":"10","author":"Kamran","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.biopha.2025.118654_bib54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118654_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"issue":"10","key":"10.1016\/j.biopha.2025.118654_bib56","doi-asserted-by":"crossref","first-page":"24873","DOI":"10.3390\/ijms161024873","article-title":"Antiproliferative activity and in vivo toxicity of Double-Point modified analogs of 1,25-Dihydroxyergocalciferol","volume":"16","author":"Trynda","year":"2015","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-018-0700-2","article-title":"Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?","volume":"41","author":"Hasselbalch","year":"2019","journal-title":"Semin Immunopathol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118654_bib58","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3109\/10428194.2013.790022","article-title":"Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors","volume":"54","author":"van Besien","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.biopha.2025.118654_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2017.02.004","article-title":"Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia","volume":"50","author":"Ghosh","year":"2017","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118654_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.2021012788","article-title":"Targeting cholesterol homeostasis in hematopoietic malignancies","volume":"139","author":"Brendolan","year":"2022","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.biopha.2025.118654_bib61","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1073\/pnas.84.21.7488","article-title":"Inhibition of hydroxymethylglutaryl-coenzyme a synthase by L-659,699","volume":"84","author":"Greenspan","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118654_bib62","article-title":"Hymeglusin enhances the Pro-Apoptotic effects of venetoclax in acute myeloid leukemia","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118654_bib63","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/CIRCULATIONAHA.110.975284","article-title":"Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia","volume":"123","author":"Stein","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","article-title":"Current status and research directions in acute myeloid leukemia","volume":"14","author":"Kantarjian","year":"2024","journal-title":"Blood Cancer J."},{"issue":"11","key":"10.1016\/j.biopha.2025.118654_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113225","article-title":"Advances in acute myeloid leukemia: recently approved therapies and drugs in development","volume":"12","author":"Stanchina","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.biopha.2025.118654_bib66","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.leu.2403899","article-title":"Cell line OCI\/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin","volume":"19","author":"Quentmeier","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.biopha.2025.118654_bib67","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/blood.V79.9.2378.2378","article-title":"Frequent mutations in the p53 gene in human myeloid leukemia cell lines","volume":"79","author":"Sugimoto","year":"1992","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.biopha.2025.118654_bib68","article-title":"Zebrafish models of acute leukemias: current models and future directions","volume":"10","author":"Molina","year":"2021","journal-title":"Wiley Inter. Rev. Dev. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118654_bib69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.trecan.2020.03.012","article-title":"Zebrafish xenografts for drug discovery and personalized Medicine","volume":"6","author":"Xiao","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2025.118654_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117395","article-title":"Shikonin, a natural naphthoquinone phytochemical, exerts anti-leukemia effects in human CBF-AML cell lines and zebrafish xenograft models","volume":"179","author":"Yen","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118654_bib71","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: new perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.biopha.2025.118654_bib72","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40268-023-00442-6","article-title":"Simvastatin preferentially targets FLT3\/ITD acute myeloid leukemia by inhibiting MEK\/ERK and p38-MAPK signaling pathways","volume":"23","author":"Li","year":"2023","journal-title":"Drugs R. D."},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib73","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s44321-024-00024-2","article-title":"Targeting the mevalonate or wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells","volume":"16","author":"Mueller","year":"2024","journal-title":"EMBO Mol. Med"},{"issue":"7","key":"10.1016\/j.biopha.2025.118654_bib74","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1158\/0008-5472.CAN-06-4093","article-title":"Cholesterol starvation induces differentiation of human leukemia HL-60 cells","volume":"67","author":"S\u00e1nchez-Mart\u00edn","year":"2007","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.biopha.2025.118654_bib75","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ccell.2023.04.016","article-title":"Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity","volume":"41","author":"Yan","year":"2023","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/stmcls\/sxad095","article-title":"Aberrant lipid metabolic signatures in acute myeloid leukemia","volume":"42","author":"Singh","year":"2024","journal-title":"Stem Cells"},{"issue":"25","key":"10.1016\/j.biopha.2025.118654_bib77","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.2020008551","article-title":"Very long chain fatty acid metabolism is required in acute myeloid leukemia","volume":"137","author":"Tcheng","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.biopha.2025.118654_bib78","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/sj.leu.2402196","article-title":"Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells","volume":"15","author":"Xia","year":"2001","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.biopha.2025.118654_bib79","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1182\/blood-2012-01-403493","article-title":"Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3\/ITD leukemia","volume":"120","author":"Williams","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib80","doi-asserted-by":"crossref","first-page":"430","DOI":"10.20517\/cdr.2023.20","article-title":"Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells","volume":"6","author":"Jansen","year":"2023","journal-title":"Cancer Drug Resist"},{"issue":"6","key":"10.1016\/j.biopha.2025.118654_bib81","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/blood-2004-01-0395","article-title":"Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells","volume":"104","author":"Banker","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib82","article-title":"Increased small extracellular vesicle secretion after chemotherapy via upregulation of cholesterol metabolism in acute myeloid leukaemia","volume":"9","author":"Hong","year":"2020","journal-title":"J. Extra Vesicles"},{"key":"10.1016\/j.biopha.2025.118654_bib83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fonc.2020.00155","article-title":"Fatty acid metabolism, bone marrow adipocytes, and AML","volume":"10","author":"Tabe","year":"2020","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib84","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI38942","article-title":"Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction","volume":"120","author":"Samudio","year":"2010","journal-title":"J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.biopha.2025.118654_bib85","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.leukres.2014.11.027","article-title":"Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy","volume":"39","author":"Erba","year":"2015","journal-title":"Leuk. Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118654_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bjh.19519","article-title":"Combination therapy with novel agents for acute myeloid leukaemia: insights into treatment of a heterogenous disease","volume":"205","author":"Jen","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118654_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06255","article-title":"Combination of coumarin and doxorubicin induces drug-resistant acute myeloid leukemia cell death","volume":"7","author":"Al-Abbas","year":"2021","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.biopha.2025.118654_bib88","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41419-020-02762-w","article-title":"Combining triptolide with ABT-199 is effective against acute myeloid leukemia through reciprocal regulation of Bcl-2 family proteins and activation of the intrinsic apoptotic pathway","volume":"11","author":"Shi","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:29:35Z","timestamp":1778754575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":88,"alternative-id":["S0753332225008480"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118654","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Jaceosidin, a natural polymethoxyflavone, suppresses leukemia cell growth and impairs lipid metabolism-dependent survival in AML and cytarabine-resistant cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118654"}}